Publications

Letter to the editor (12 POSTS)

2024 (1 POST)

Oller A, Barroso J, Prieto P, Verougstraete V, Heim K, Henderson R. 2024. Response to letter to editors submitted by PE Rasmussen, P Huntsman, TM Singer, MN Jacobs, and CC Trevithick-Sutton (Aug 2024). Regul Toxicol Pharmacol 154(Dec):105740; doi: 10.1016/j.yrtph.2024.105740. PMID: 39557211.

View Abstract

2019 (2 POSTS)

Burns AM, Barlow CA, Banducci AM, Unice KM, Sahmel J. 2019. Letter to the editor: Response to letter to the editor (Finkelstein 39(12):2601-2603). Risk Anal 39(12):2604-2607; doi: 10.1111/risa.13418. PMID: 31797415.

Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019. Response to letters regarding “Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period.” Inhal Toxicol 31(11–12):387–391; doi: 10.1080/08958378.2019.1702744. PMID: 31851545.

    View Abstract

    2018 (1 POST)

    Wikoff DS, Miller GW. 2018. Systematic reviews in toxicology (Editorial). Toxicol Sci 163(2):335–337; doi: 10.1093/toxsci/kfy109. PMID: 29850908.

    View Abstract

    2016 (2 POSTS)

    Garabrant DH, Alexander DD, Miller PE, Fryzek JP, Boffetta P, Teta MJ, Hessel PA,.., Kelsh MA, et al. 2016. Response to Kay Teschke. Re: Mesothelioma among motor vehicle mechanics: An updated review and meta-analysis. Ann Occup Hyg 60(8):1036-1037; doi: 10.1093/annhyg/mew038. PMID: 27328807.

    View Abstract

    Pierce JS, Abelmann A, Finley BL. 2016. Comment on flavoring chemicals in e-cigarettes: Diacetyl, 2,-3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Persp 124(6):A100–A101; doi: 10.1289/ehp.1611350. PMID: 27248354.

    View Abstract

    2015 (1 POST)

    Sacks NC, Ash AS, Ghosh K, Rosen AK, Wong JB, Cutler DM, Rosen AB. 2015. Recent national trends in acute myocardial infarction hospitalizations in Medicare: Shrinking declines and growing disparities [Letter to the Editor]. Epidemiol 26(4):e46–47; doi: 10.1097/EDE.0000000000000298. PMID: 25924109.

    View Abstract

    2014 (2 POSTS)

    Paustenbach D, Galbraith D, Finley B. 2014. Letter to the Editor: Authors’ response to letters to the editor re: Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(5):569–570; doi: 10.3109/15563650.2014.908473. PMID: 24766481.

    View Abstract

    James RC, Britt J, Halmes N, Guzelian P. 2014. Comments on recent discussions providing differing causation methodologies. Hum Experim Toxicol 33(1):109-112; doi: 10.1177/0960327113491511. PMID: 23749455.

    View Abstract

    2013 (1 POST)

    Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Response to Goldstein et al. J Occup Environ Med 55(11):1378; doi: 10.1097/JOM.0000000000000021. PMID: 24202246. PMID: 24202246.

    View Abstract

    2006 (1 POST)

    Kelsh MA, Berman DW, Langer AW. 2006. Residential proximity to naturally occurring asbestos and mesothelioma risks: Further consideration of exposure misclassification and occupational confounding. Am J Respir Crit Care Med 174(12):1400; doi: 10.1164/ajrccm.174.12.1400. PMID: 17158287.

    View Abstract

    2000 (1 POST)

    Finley BL, Proctor DM, Harris MA, Fowler JF. 2000. Letter to the editor: Patch testing for chromium sensitivity. American J Contact Derm 11(2)123-125; doi:  10.1053/ac.2000.6339.